Overview

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-C52H in healthy adults
Phase:
Phase 1
Details
Lead Sponsor:
AJU Pharm Co., Ltd.
Treatments:
Cryptophycin 52